Alaunos Therapeutics(TCRT) - 2024 Q3 - Quarterly Results
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 4, 2024 Alaunos Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33038 (State or other jurisdiction of incorporation) (Commission File Number) | --- | --- | |------------|-------| | | | | | | | | | | | | | | | | | | | 84-1475642 | | | | | | | | | (I ...